Literature DB >> 20668479

Medical oncology: Optimizing chemotherapy and radiotherapy for anaplastic glioma.

Patrick G Morris, Andrew B Lassman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20668479     DOI： 10.1038/nrclinonc.2010.98

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

1.  Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].

Authors:  Lisa M DeAngelis
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

2.  Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

Authors:  Gregory Cairncross; Brian Berkey; Edward Shaw; Robert Jenkins; Bernd Scheithauer; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperierre; Minesh Mehta; Walter Curran
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

3.  Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.

Authors:  Martin J van den Bent; Antoine F Carpentier; Alba A Brandes; Marc Sanson; Martin J B Taphoorn; Hans J J A Bernsen; Marc Frenay; Cees C Tijssen; Wolfgang Grisold; Laslo Sipos; Hanny Haaxma-Reiche; Johannes M Kros; Mathilde C M van Kouwenhoven; Charles J Vecht; Anouk Allgeier; Denis Lacombe; Thierry Gorlia
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

4.  Survey of treatment recommendations for anaplastic oligodendroglioma.

Authors:  Lauren E Abrey; David N Louis; Nina Paleologos; Andrew B Lassman; Jeffrey J Raizer; Warren Mason; Jonathan Finlay; David R MacDonald; Lisa M DeAngelis; J Gregory Cairncross
Journal:  Neuro Oncol       Date:  2007-04-13       Impact factor: 12.300

5.  NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.

Authors:  Wolfgang Wick; Christian Hartmann; Corinna Engel; Mandy Stoffels; Jörg Felsberg; Florian Stockhammer; Michael C Sabel; Susanne Koeppen; Ralf Ketter; Richard Meyermann; Marion Rapp; Christof Meisner; Rolf D Kortmann; Torsten Pietsch; Otmar D Wiestler; Ulrike Ernemann; Michael Bamberg; Guido Reifenberger; Andreas von Deimling; Michael Weller
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

6.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

7.  IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

Authors:  Martin J van den Bent; Hendrikus J Dubbink; Yannick Marie; Alba A Brandes; Martin J B Taphoorn; Pieter Wesseling; Marc Frenay; Cees C Tijssen; Denis Lacombe; Ahmed Idbaih; Ronald van Marion; Johan M Kros; Winand N M Dinjens; Thierry Gorlia; Marc Sanson
Journal:  Clin Cancer Res       Date:  2010-02-16       Impact factor: 13.801
  7 in total
  6 in total

1.  Initial treatment patterns over time for anaplastic oligodendroglial tumors.

Authors:  Katherine S Panageas; Fabio M Iwamoto; Timothy F Cloughesy; Kenneth D Aldape; Andreana L Rivera; April F Eichler; David N Louis; Nina A Paleologos; Barbara J Fisher; Lynn S Ashby; J Gregory Cairncross; Gloria B Roldán Urgoiti; Patrick Y Wen; Keith L Ligon; David Schiff; H Ian Robins; Brandon G Rocque; Marc C Chamberlain; Warren P Mason; Susan A Weaver; Richard M Green; Francois G Kamar; Lauren E Abrey; Lisa M Deangelis; Suresh C Jhanwar; Marc K Rosenblum; Andrew B Lassman
Journal:  Neuro Oncol       Date:  2012-05-31       Impact factor: 12.300

2.  International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.

Authors:  Andrew B Lassman; Fabio M Iwamoto; Timothy F Cloughesy; Kenneth D Aldape; Andreana L Rivera; April F Eichler; David N Louis; Nina A Paleologos; Barbara J Fisher; Lynn S Ashby; J Gregory Cairncross; Gloria B Roldán; Patrick Y Wen; Keith L Ligon; David Schiff; H Ian Robins; Brandon G Rocque; Marc C Chamberlain; Warren P Mason; Susan A Weaver; Richard M Green; Francois G Kamar; Lauren E Abrey; Lisa M DeAngelis; Suresh C Jhanwar; Marc K Rosenblum; Katherine S Panageas
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

3.  Effects of small nucleolar RNA SNORD44 on the proliferation, apoptosis and invasion of glioma cells.

Authors:  Xian-Ru Xia; Wen-Cui Li; Zong-Tao Yu; Jie Li; Chun-Yan Peng; Li Jin; Guo-Lin Yuan
Journal:  Histochem Cell Biol       Date:  2020-02-15       Impact factor: 4.304

4.  Overexpressed P75CUX1 promotes EMT in glioma infiltration by activating β-catenin.

Authors:  Anqi Xu; Xizhao Wang; Jie Luo; Mingfeng Zhou; Renhui Yi; Tengyue Huang; Jie Lin; Zhiyong Wu; Cheng Xie; Shengfeng Ding; Yu Zeng; Ye Song
Journal:  Cell Death Dis       Date:  2021-02-04       Impact factor: 8.469

5.  MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients.

Authors:  Chunyu Zhang; Haitao Liu; Yinqiu Tan; Yang Xu; Yuntao Li; Shiao Tong; Sheng Qiu; Qianxue Chen; Zhongzhou Su; Daofeng Tian; Wei Zhou; Chunlong Zhong
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

6.  Nucleolar and spindle associated protein 1 promotes the aggressiveness of astrocytoma by activating the Hedgehog signaling pathway.

Authors:  Xianqiu Wu; Benke Xu; Chao Yang; Wentao Wang; Dequan Zhong; Zhan Zhao; Longshuang He; Yuanjun Hu; Lili Jiang; Jun Li; Libing Song; Wei Zhang
Journal:  J Exp Clin Cancer Res       Date:  2017-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.